Perspective Therapeutics, Inc. — Form D

Perspective Therapeutics, Inc. of Seattle, WA, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-18. The offering totals $87.4M, of which $87.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Heidi HensonDirectorSeattle, WA
Frank MorichDirectorBoston, MA
Johan (Thijs) SpoorDirectorSeattle, WA
Robert Williamson IIIDirectorSeattle, WA
Lori WoodsDirectorSeattle, WA
Mark AustinExecutive OfficerSeattle, WA
Jonathan HuntExecutive OfficerNew York, NY
Markus PuhlmannExecutive OfficerSeattle, WA
Johan (Thijs) SpoorExecutive OfficerSeattle, WA
Michael McCormickDirectorNew York, NY
Jennifer StreeterExecutive OfficerRichland, WA
William J CavanaghExecutive OfficerRichland, WA
Michael W McCormickDirectorScottsdale, AZ
Lori A WoodsDirectorRichland, WA
Lori A WoodsExecutive OfficerRichland, WA
Jennifer J StreeterExecutive OfficerRichland, WA
Mark J AustinExecutive OfficerRichland, WA
Michael J KrachonExecutive OfficerRichland, WA
Alan J HoffmannDirectorPhoenix, AZ
Philip J VitaleDirectorScottsdale, AZ

Other filings by this issuer (3)

FiledFormOfferingSold
2024-01-22D$20.8M$20.8M
2023-02-21D$54.6M$54.6M
2018-07-25D$729K$729K

More